Primary overall survival analysis of the phase 3 randomized ZUMA‐7 study of axicabtagene ciloleucel versus standard of care in relapsed/refractory large B‐cell lymphoma Meeting Abstract
| Authors: | Westin, J. R.; Oluwole, O. O.; Kersten, M. J.; Miklos, D. B.; Perales, M. A; Ghobadi, A.; Rapoport, A. P.; Sureda, A.; Jacobson, C. A.; Farooq, U.; van Meerten, T.; Ulrickson, M. L.; Elsawy, M.; Leslie, L. A.; Chaganti, S.; Dickinson, M.; Yang, Y.; Schupp, M.; To, C.; Locke, F. L. |
| Abstract Title: | Primary overall survival analysis of the phase 3 randomized ZUMA‐7 study of axicabtagene ciloleucel versus standard of care in relapsed/refractory large B‐cell lymphoma |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 52 |
| End Page: | 54 |
| Language: | English |
| DOI: | 10.1002/hon.3163_22 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 022 -- Source: Cinahl |
